IDRSF
Price
$4.70
Change
+$1.40 (+42.42%)
Updated
Sep 23 closing price
Capitalization
956.18M
IVBXF
Price
$12.10
Change
-$0.40 (-3.20%)
Updated
Sep 23 closing price
Capitalization
20.55B
Interact to see
Advertisement

IDRSF vs IVBXF

Header iconIDRSF vs IVBXF Comparison
Open Charts IDRSF vs IVBXFBanner chart's image
Idorsia AG
Price$4.70
Change+$1.40 (+42.42%)
Volume$1.88K
Capitalization956.18M
Innovent Biologics
Price$12.10
Change-$0.40 (-3.20%)
Volume$2.18K
Capitalization20.55B
IDRSF vs IVBXF Comparison Chart in %
Loading...
IDRSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IVBXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDRSF vs. IVBXF commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDRSF is a Buy and IVBXF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (IDRSF: $4.70 vs. IVBXF: $12.10)
Brand notoriety: IDRSF and IVBXF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDRSF: 80% vs. IVBXF: 4%
Market capitalization -- IDRSF: $956.18M vs. IVBXF: $20.55B
IDRSF [@Biotechnology] is valued at $956.18M. IVBXF’s [@Biotechnology] market capitalization is $20.55B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDRSF’s FA Score shows that 0 FA rating(s) are green whileIVBXF’s FA Score has 0 green FA rating(s).

  • IDRSF’s FA Score: 0 green, 5 red.
  • IVBXF’s FA Score: 0 green, 5 red.
According to our system of comparison, IVBXF is a better buy in the long-term than IDRSF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDRSF’s TA Score shows that 4 TA indicator(s) are bullish while IVBXF’s TA Score has 3 bullish TA indicator(s).

  • IDRSF’s TA Score: 4 bullish, 4 bearish.
  • IVBXF’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, IDRSF is a better buy in the short-term than IVBXF.

Price Growth

IDRSF (@Biotechnology) experienced а +42.42% price change this week, while IVBXF (@Biotechnology) price change was -6.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.31%. For the same industry, the average monthly price growth was +10.10%, and the average quarterly price growth was +53.89%.

Industries' Descriptions

@Biotechnology (+4.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IVBXF($20.5B) has a higher market cap than IDRSF($956M). IVBXF has higher P/E ratio than IDRSF: IVBXF (128.47) vs IDRSF (4.54). IDRSF YTD gains are higher at: 452.941 vs. IVBXF (168.889).
IDRSFIVBXFIDRSF / IVBXF
Capitalization956M20.5B5%
EBITDA-83.29MN/A-
Gain YTD452.941168.889268%
P/E Ratio4.54128.474%
Revenue217MN/A-
Total Cash82.2MN/A-
Total Debt1.3BN/A-
FUNDAMENTALS RATINGS
IDRSF vs IVBXF: Fundamental Ratings
IDRSF
IVBXF
OUTLOOK RATING
1..100
3197
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
85
Overvalued
PROFIT vs RISK RATING
1..100
10066
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
3738
P/E GROWTH RATING
1..100
9861
SEASONALITY SCORE
1..100
9038

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IDRSF's Valuation (79) in the null industry is in the same range as IVBXF (85). This means that IDRSF’s stock grew similarly to IVBXF’s over the last 12 months.

IVBXF's Profit vs Risk Rating (66) in the null industry is somewhat better than the same rating for IDRSF (100). This means that IVBXF’s stock grew somewhat faster than IDRSF’s over the last 12 months.

IVBXF's SMR Rating (97) in the null industry is in the same range as IDRSF (100). This means that IVBXF’s stock grew similarly to IDRSF’s over the last 12 months.

IDRSF's Price Growth Rating (37) in the null industry is in the same range as IVBXF (38). This means that IDRSF’s stock grew similarly to IVBXF’s over the last 12 months.

IVBXF's P/E Growth Rating (61) in the null industry is somewhat better than the same rating for IDRSF (98). This means that IVBXF’s stock grew somewhat faster than IDRSF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IDRSFIVBXF
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
63%
Bullish Trend 1 day ago
71%
Momentum
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
61%
MACD
ODDS (%)
Bullish Trend 1 day ago
58%
Bearish Trend 1 day ago
59%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
57%
Bearish Trend 1 day ago
64%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
53%
Bearish Trend 1 day ago
61%
Advances
ODDS (%)
N/A
Bullish Trend 13 days ago
70%
Declines
ODDS (%)
N/A
Bearish Trend 17 days ago
56%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
67%
Aroon
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
IDRSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IVBXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATER1.040.05
+4.82%
Aterian
BSBR5.560.12
+2.21%
Banco Santander (Brasil) SA
FLL3.46-0.02
-0.57%
Full House Resorts
PRAA16.44-0.26
-1.56%
PRA Group
PGY37.66-3.64
-8.81%
Pagaya Technologies Ltd

IDRSF and

Correlation & Price change

A.I.dvisor tells us that IDRSF and CADL have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IDRSF and CADL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDRSF
1D Price
Change %
IDRSF100%
+42.42%
CADL - IDRSF
25%
Poorly correlated
+1.15%
NDTP - IDRSF
22%
Poorly correlated
-11.85%
ANNX - IDRSF
22%
Poorly correlated
-2.35%
HRTX - IDRSF
21%
Poorly correlated
-4.62%
LGVN - IDRSF
21%
Poorly correlated
+0.96%
More

IVBXF and

Correlation & Price change

A.I.dvisor tells us that IVBXF and WXXWY have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IVBXF and WXXWY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVBXF
1D Price
Change %
IVBXF100%
-3.20%
WXXWY - IVBXF
24%
Poorly correlated
-0.17%
BNTC - IVBXF
23%
Poorly correlated
-2.15%
MBXBF - IVBXF
7%
Poorly correlated
N/A
ISCO - IVBXF
5%
Poorly correlated
N/A
IDRSF - IVBXF
4%
Poorly correlated
+42.42%
More